Literature DB >> 12091379

Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5'-AMP-activated protein kinase-dependent manner.

Hiroyasu Esumi1, Kunihiko Izuishi, Kazuyoshi Kato, Koichi Hashimoto, Yukiko Kurashima, Atsuhiro Kishimoto, Tsutomu Ogura, Takayuki Ozawa.   

Abstract

Hypoxia is a critical event for higher organisms, and cells and tissues react by increasing the oxygen supply by vasodilatation, angiogenesis, and erythropoiesis and maintaining cellular energy by increasing glycolysis and inhibiting anabolic pathways. Stimulation of glycolysis has been regarded as the main response that increases energy production during hypoxia; however, there is an obvious conflict during ischemia, because both the oxygen and glucose supply are insufficient. In this study, we found that exposure of HepG2 cells and normal fibroblasts to hypoxia induces cellular tolerance to glucose starvation. The tolerance induced by hypoxia is dependent on several amino acids, indicating a switch from glucose to amino acids as the energy source. When antisense RNA expression vector for 5'-AMP-activated protein kinase or protein kinase B/Akt was transfected into HepG2 cells, the induction of tolerance to glucose was greatly inhibited, indicating that the tolerance was dependent on 5'-AMP-activated protein kinase and protein kinase B/Akt. Similar tolerance was induced by nitric oxide exposure. The tolerance induced was observed in various cells and may represent a previously unknown physiological response related to hypoxia-preconditioning and tumor progression:austerity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091379     DOI: 10.1074/jbc.M112270200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Binucleated HeLa cells are formed by cytokinesis failure in starvation and keep the potential of proliferation.

Authors:  Kazunori Nishimura; Sumiko Watanabe; Ryo Hayashida; Setsuo Sugishima; Tsuyoshi Iwasaka; Tsunehisa Kaku
Journal:  Cytotechnology       Date:  2015-04-18       Impact factor: 2.058

2.  5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

Authors:  Keith R Laderoute; Khalid Amin; Joy M Calaoagan; Merrill Knapp; Theresamai Le; Juan Orduna; Marc Foretz; Benoit Viollet
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas.

Authors:  Efthimios Sivridis; Michael I Koukourakis; Christos E Zois; Ioanna Ledaki; David J P Ferguson; Adrian L Harris; Kevin C Gatter; Alexandra Giatromanolaki
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

4.  A pull-down assay for 5' AMP-activated protein kinase activity using the GST-fused protein.

Authors:  Atsuhiro Kishimoto; Tsutomu Ogura; Hiroyasu Esumi
Journal:  Mol Biotechnol       Date:  2006-01       Impact factor: 2.695

5.  Purinergic receptor antagonism prevents cold preservation-induced cell death independent of cellular ATP levels.

Authors:  Christopher D Anderson; Janene Pierce; Ian B Nicoud; Andrey E Belous; Christopher M Jones; Ravi S Chari
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

6.  Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation.

Authors:  Takeo Toshima; Ken Shirabe; Yoshihiro Matsumoto; Shohei Yoshiya; Toru Ikegami; Tomoharu Yoshizumi; Yuji Soejima; Tetsuo Ikeda; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2013-05-24       Impact factor: 7.527

7.  ARK5 is a tumor invasion-associated factor downstream of Akt signaling.

Authors:  Atsushi Suzuki; Jie Lu; Gen-Ichi Kusakai; Atsuhiro Kishimoto; Tsutomu Ogura; Hiroyasu Esumi
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Effect of nutrient deprivation on the viability of intervertebral disc cells.

Authors:  S R S Bibby; J P G Urban
Journal:  Eur Spine J       Date:  2004-03-27       Impact factor: 3.134

9.  ARK5 expression in colorectal cancer and its implications for tumor progression.

Authors:  Gen-ichi Kusakai; Atsushi Suzuki; Tsutomu Ogura; Sin'ichi Miyamoto; Atsushi Ochiai; Michio Kaminishi; Hiroyasu Esumi
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 10.  Role of ARK5 in cancer and other diseases (Review).

Authors:  Guoheng Mo; Bohan Zhang; Qunguang Jiang
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.